Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q1 2021 · 10-Q
Revenue$2.03B$2.03B+0.7% vs Q1 2020 Net Income-$610.00M-$610.00MN/M vs Q1 2020 EPS Diluted-$1.71-$1.71N/M vs Q1 2020 Operating Income-$221,000,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$377,000,000+99.5% Margins · derivedOperating margin-10.9%−23.2 pt vs Q1 2020
Net margin-30.1%−22.5 pt vs Q1 2020
ended Mar 31, 2021 · filed May 4, 2021 · 34 d after period end